# 119-s-2372: 340B PATIENTS Act of 2025

119-s-2372, 340B PATIENTS Act of 2025, is a 119th Congress bill sponsored by Sen. Welch, Peter [D-VT] (D-VT); status introduced; PRIA reads it as touching household money (as of 2025-12-21).

- Canonical: https://policyrisk.com/legislation/119-s-2372
- As of: 2025-12-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-2372
- Congress: 119
- Title: 340B PATIENTS Act of 2025
- Status: introduced
- Introduced: 2025-07-22
- Sponsor: Sen. Welch, Peter [D-VT] (D-VT)
- Cosponsors: 2
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2025-12-21

## Summary

**Protecting 340B discounts at contract pharmacies** would clarify that drugmakers must offer 340B discounted prices for outpatient drugs regardless of where a covered entity has them dispensed and would bar conditions that limit purchasing or delivery. - Patients and families: Would help preserve access to discounted outpatient drugs by ensuring prescriptions filled at contract pharmacies remain eligible for 340B pricing, including specialty drugs that are often handled offsite. - Safety-net providers and covered entities: Would let hospitals, clinics, and other covered entities rely on contract pharmacies to dispense their 340B drugs and keep program savings available to fund patient care and community services. - Pharmacies and manufacturers: Would prohibit manufacturers from imposing conditions that restrict delivery, purchasing mechanisms, or require extra assurances or data when covered entities use contract pharmacies. It would also clarify that manufacturers' discount obligations follow covered entities that elect to use contract pharmacies.

## Cosponsors (2)

- Sen. Merkley, Jeff [D-OR] (D-OR), 2025-07-22T00:00:00.000Z
- Sen. Cantwell, Maria [D-WA] (D-WA), 2025-07-29T00:00:00.000Z

## Provisions PRIA read

- Protect 340B patients' pharmacy access: benefit, medium. If enacted, this bill would let covered 340B providers contract with pharmacies to fill discounted outpatient drugs. It would require drug manufacturers to offer 340B prices regardless of where a drug is dispensed. Manufacturers could not impose conditions that stop a provider from using a pharmacy…

## Related bills

- 119-s-524: Coast Guard Authorization Act of 2025
- 119-s-3869: Healthy Families Act
- 119-s-51: Washington, D.C. Admission Act
- 119-s-5108: Right to IVF Act of 2026
- 119-s-1503: Equality Act
- 119-s-4668: Protect College Sports Act of 2026

## Sources
- [119-s-2372 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/2372)

## Related
- [119-s-524: Coast Guard Authorization Act of 2025](https://policyrisk.com/legislation/119-s-524)
- [119-s-3869: Healthy Families Act](https://policyrisk.com/legislation/119-s-3869)
- [119-s-51: Washington, D.C. Admission Act](https://policyrisk.com/legislation/119-s-51)
- [119-s-5108: Right to IVF Act of 2026](https://policyrisk.com/legislation/119-s-5108)
- [119-s-1503: Equality Act](https://policyrisk.com/legislation/119-s-1503)
- [119-s-4668: Protect College Sports Act of 2026](https://policyrisk.com/legislation/119-s-4668)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-2372 (as of 2025-12-21).